Spain · Delayed Price · Currency is EUR BME:TSK Statistics
Total Valuation
BME:TSK has a market cap or net worth of EUR 714.34 million. The enterprise value is 603.98 million.
| Market Cap | 714.34M |
| Enterprise Value | 603.98M |
Important Dates
The last earnings date was Friday, September 11, 2026.
| Earnings Date | Sep 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:TSK has 118.86 million shares outstanding.
| Current Share Class | 118.86M |
| Shares Outstanding | 118.86M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 72.02% |
| Owned by Institutions (%) | 1.20% |
| Float | 33.26M |
Valuation Ratios
The trailing PE ratio is 6.64 and the forward PE ratio is 9.96. BME:TSK's PEG ratio is 0.38.
| PE Ratio | 6.64 |
| Forward PE | 9.96 |
| PS Ratio | 0.68 |
| PB Ratio | 2.43 |
| P/TBV Ratio | 2.46 |
| P/FCF Ratio | 5.91 |
| P/OCF Ratio | 5.78 |
| PEG Ratio | 0.38 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.76, with an EV/FCF ratio of 5.00.
| EV / Earnings | 8.01 |
| EV / Sales | 0.58 |
| EV / EBITDA | 9.76 |
| EV / EBIT | 9.75 |
| EV / FCF | 5.00 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.85.
| Current Ratio | 1.27 |
| Quick Ratio | 1.25 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 4.06 |
| Debt / FCF | 2.08 |
| Interest Coverage | 3.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 33.77% |
| Return on Capital Employed (ROCE) | 16.64% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 683,651 |
| Profits Per Employee | 49,140 |
| Employee Count | 1,538 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.67M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 6.15 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 53.73 |
| Average Volume (20 Days) | 175,945 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:TSK had revenue of EUR 1.05 billion and earned 75.43 million in profits. Earnings per share was 0.85.
| Revenue | 1.05B |
| Gross Profit | 323.96M |
| Operating Income | 61.98M |
| Pretax Income | 78.57M |
| Net Income | 75.43M |
| EBITDA | 61.89M |
| EBIT | 61.98M |
| Earnings Per Share (EPS) | 0.85 |
Balance Sheet
The company has 362.36 million in cash and 251.32 million in debt, with a net cash position of 111.04 million or 0.93 per share.
| Cash & Cash Equivalents | 362.36M |
| Total Debt | 251.32M |
| Net Cash | 111.04M |
| Net Cash Per Share | 0.93 |
| Equity (Book Value) | 294.57M |
| Book Value Per Share | 2.47 |
| Working Capital | 190.52M |
Cash Flow
In the last 12 months, operating cash flow was 123.55 million and capital expenditures -2.67 million, giving a free cash flow of 120.88 million.
| Operating Cash Flow | 123.55M |
| Capital Expenditures | -2.67M |
| Depreciation & Amortization | -88,000 |
| Net Borrowing | -166.25M |
| Free Cash Flow | 120.88M |
| FCF Per Share | 1.02 |
Margins
Gross margin is 30.87%, with operating and profit margins of 5.91% and 7.19%.
| Gross Margin | 30.87% |
| Operating Margin | 5.91% |
| Pretax Margin | 7.49% |
| Profit Margin | 7.19% |
| EBITDA Margin | 5.90% |
| EBIT Margin | 5.91% |
| FCF Margin | 11.52% |
Dividends & Yields
BME:TSK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 0.24% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 10.56% |
| FCF Yield | 16.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BME:TSK is 9.33, which is 46.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 9.33 |
| Price Target Difference | 46.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 10.94% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:TSK has an Altman Z-Score of 2.08 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.08 |
| Piotroski F-Score | 6 |